Xeris Pharmaceuticals Inc Cash Flow Quality Index

Latest as of March 2026: 4.42x

Xeris Pharmaceuticals Inc cash flow quality index. Xeris Pharmaceuticals Inc (XERS) has a Cash Flow Quality Index of 4.42x as of March 2026. Operating cash flow of $9.87 Million exceeds net income of $2.23 Million, indicating high earnings quality where cash backs reported profits. See Xeris Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

4.42x

Operating CF / Net Income

Operating Cash Flow

$9.87 Million

USD

Net Income

$2.23 Million

USD

Data as of

Mar 2026

Most recent filing

Cash Flow Quality Index of Xeris Pharmaceuticals Inc (2025–2025)

Cash flow quality index of Xeris Pharmaceuticals Inc from 2025 to 2025. Historical Cash Flow Quality Index for Xeris Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Xeris Pharmaceuticals Inc (XERS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Xeris Pharmaceuticals Inc Cash Flow Quality Index by Year (2025–2025)

Xeris Pharmaceuticals Inc cash flow quality index by year from 2025 to 2025. Year-by-year earnings quality comparison for Xeris Pharmaceuticals Inc. For the full cash flow conversion analysis, see Xeris Pharmaceuticals Inc operating cash flow efficiency.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2025	51.67x	$28.63 Million	$554.00K	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.